Company: APM
Filing Date: 2025-10-14
Form Type: 424B5
Source: 0001213900-25-098635
Chunk: 79

Company: Aptorum Group Ltd
Filing Date: 2025-10-14
Form: 424B5
Chunk 79
---
 information contained in this prospectus, any applicable prospectus supplement or
any related free writing prospectus is accurate on any date subsequent to the date set forth on the front of the document or that any
information we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference
(as our business, financial condition, results of operations and prospects may have changed since that date), even though this prospectus,
any applicable prospectus supplement or any related free writing prospectus is delivered or securities are sold on a later date.

As permitted by SEC rules
and regulations, the registration statement of which this prospectus forms a part includes additional information not contained in this
prospectus. You may read the registration statement and the other reports we file with the SEC at its website or at its offices described
below under “Where You Can Find More Information.”

Unless the context otherwise
requires, all references in this prospectus to “Aptorum,” “we,” “us,” “our,” “the
Company” or similar words refer to Aptorum Group Limited, together with our subsidiaries.

<div align='center'>ii

COMMONLY USED DEFINED TERMS</div>

| ● | “505(b)(2) Application” refers to an application for which one or more of the investigations relied upon by the applicant for approval “were not conducted by or for the applicant and for which the applicant has not obtained a right of reference or use from the person by or for whom the investigations were conducted” (21 U.S.C. 355(b)(2)).                                                                                                                                                                   |
| ● | “A*STAR” refers to Agency for Science, Technology and Research                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| ● | “Acticule” refers to Acticule Life Sciences Limited, an 80% owned subsidiary of Aptorum Group.                                                                                                                                                                                                                                                                                                                                                                                                                         |
| ● | “Aeneas Group” refers to Aeneas Limited and its subsidiaries. Aeneas Limited is 76.8% owned by Jurchen Investment Corporation. Because Mr. Huen, a director holds 100% equity interest in Jurchen Investment Corporation, we refer Aeneas Group as a fellow subsidiary of Aptorum Group.                                                                                                                                                                                                                               |
| ● | “AGP” refers to A.G.P./Alliance Global Partners, the placement agent for the February 2020 Offering (as defined below).                                                                                                                                                                                                                                                                                                                                                                                                |
| ● | “AML” refers to Aptorum Medical Limited, a 91% owned subsidiary of Apt